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Epidermolytic hyperkeratosis is characterized by tono-
filament clumping, cytolysis, and blister formation in
suprabasal keratinocytes. It has been shown that the
tonofilament aggregates in these areas are composed
of keratin 1 (K1) and keratin 10 (K10), and several K1
and K10 point mutations have been identified as the
molecular basis of epidermolytic hyperkeratosis. In this
report we identify a novel, single base pair substitution
resulting in an amino acid exchange from tyrosine to
serine at residue 14 within the conserved 1A region of
K10 (Y14S). This A to C transversion in codon 160
Epidermolytic hyperkeratosis (EHK), also known asbullous congenital ichthyosiform erythroderma [EHK/BCIE, MIM #113800], is a blistering disorder resultingfrom mutations in highly conserved regions of keratinsK1 and K10 (Cheng et al, 1992; Chipev et al, 1992;
Rothnagel et al, 1994). At birth, affected individuals usually present
with redness, blisters, and superficial erosions due to cytolysis
(acanthokeratolysis). Within a few weeks, the erythroderma and
blister formation usually diminish with the concommittant develop-
ment of hyperkeratoses. The disease is transmitted in an autosomal
dominant mode, but most cases are sporadic, representing new
mutations, and several such mutations have been described. Mor-
phologically, the suprabasal layers of the epidermis are affected by
collapse of the keratin network, with filament clumps surrounding
the nucleus (Anton-Lamprecht, 1994). In EHK, several point
mutations have been described in highly conserved terminal regions
of the rod domain and even subtle amino acid substitutions at the
ends of the rod domain can be deleterious for filament assembly
(Corden and McLean, 1996; Rothnagel, 1996).
In this paper, we describe a case of EHK caused by a novel
point mutation leading to a tyrosine to serine (Y14S) change in
the 1A region of K10. This amino acid substitution was associated
with a particularly severe phenotype. These findings document
that alterations in this position of the helix initiation motif can be
deleterious to filament assembly and stability.
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was only present in the affected individual and was
associated with a very severe disease phenotype. Our
observations are in agreement with previous reports
documenting that this tyrosine residue, located at the
beginning of the rod domain of type I keratins, is
particularly sensitive to amino acid substitutions, and
that alterations in this residue can have deleterious
effects on filament assembly and stability. Key words:
epidermolytic hyperkeratosis/genodermatosis/intermediate
filaments/keratin 10. J Invest Dermatol 112:506–508, 1999
MATERIALS AND METHODS
Automated sequencing of the 1A region of the K10 gene Human
genomic DNA was extracted from blood as previously described (Rothnagel
et al, 1992). Exon 1, which encodes the 1A region of K10, was amplified
from genomic DNA using the oligonucleotide primers HK10M26 (59
CTCAAGCAAGCACTACTCTTCCTC 39) and HK10M27 (59 GCA-
CACTTGCTGGATGAAGATTGC 39). The amplified product was puri-
fied with a PCR Purification Kit (Qiagen, Valencia, CA). Automated
fluorescence sequencing was performed using the sequencing primer
HK10 J17 (59 GTATTTGCTGTAGTCACGAGGCTC 39).
RESULTS
Clinical description of the EHK patient The affected indi-
vidual (II.1) (Fig 1) was born at term as the first child of healthy,
unrelated parents after one previous miscarriage. A healthy brother
was born 7 y later and there was no family history of skin diseases.
Figure 1. Pedigree of the family. Men are represented by squares and
women by circles. The solid symbol denotes the patient (II.1).
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Figure 2. Clinical and histologic features of patient II.1. (a) Skin at
birth with prominent hyperkeratoses; (b) plantar hyperkeratoses; (c) back
of right foot with hyperkeratoses and superficial erosions at the age of 5
1/3 y, note pronounced vulnerability; (d) semi-thin section. Note that the
epidermis is acanthotic and covered with a prominent, loose horney cell
layer in which the remnants of clumped keratins are preserved. Keratin
clumping is apparent in the epidermis from the first suprabasal layer
upwards. Also, there is increasing edema in the upper layers, but blisters
are not observed. The basal cells are normal. Biopsy at 18 mo. Scale
bar: 100 µm.
At birth, the proband presented with severe generalized skin
involvement with blisters, erosions, and widespread detachment of
the thickened hyperkeratotic skin (Fig 2a). The clinical picture
was initially mistaken as epidermolysis bullosa simplex. Blisters
and erosions persisted throughout childhood in spite of severe
hyperkeratoses that included the face, palms, and soles (Fig 2b, c).
Nails, teeth, and hair were normal. Treatment with emollients and
urea-containing ointments was initiated in early childhood, but
with minimal success. At the age of five, systemic treatment with
retinoids led to an improvement of the skin condition, with
diminishing hyperkeratoses. Attempts to remove the hyperkeratoses
mechanically irritated her skin, leading to a compensatory increase
in hyperproliferation and hyperkeratosis.
Light and electron microscopy A skin biopsy was obtained
during the neonatal period; however, it was examined elsewhere
and the results were not available for evaluation. At 18 mo of age,
a second biopsy was investigated by light and electron microscopy
and showed normal basal cells but pronounced clumping of keratin
Figure 3. Electron micrograph. Prickle cells in the lower epidermis
with clumps and aggregations of suprabasal keratins (arrowheads) involving
the entire keratin network around the cell nuclei (N); as a result most
areas of the cytoplasm are devoid of a cytoskeleton. Focal cytolysis is visible
in some of the cells (asterisks). Biopsy at 18 mo. Scale bar: 10 µm.
filaments in all suprabasal epidermal layers leading to a total
collapse of the cytoskeleton, confirming the diagnosis of EHK.
The epidermis was acanthotic, and the horney cell layer was
severely hyperkeratotic with the clumped keratin filaments still
visible (Fig 2d). By electron microscopy, keratohyalin granules
were of normal texture and density, but mostly rounded and
attached laterally to the dense aggregates of clumped keratin
filaments (Fig 3). The keratinocytes in the upper layers displayed
mild cytolysis, but no blisters were recognizable.
Identification of a tyrosine to serine substitution in position
14 of the 1A subdomain of keratin 10 Genomic DNA from
II.1 and both unaffected parents (I.1 and I.2) was amplified
and the polymerase chain reaction products were sequenced.
Fluorescence automated sequencing of amplified genomic DNA
from II.1 revealed an A to C transversion at codon 160 of the K10
gene, causing an amino acid change from tyrosine to serine (Y→S)
(TAC→TCC). The sequence from both unaffected parents (I.1
and I.2) showed the wild-type sequence at codon 160 (TAC)
(Fig 4). This mutation was not detected in 100 normal K10 alleles
analyzed by allele-specific PCR.
DISCUSSION
The patient presented in this paper showed severe clinical features
at birth that were first misdiagnosed as epidermolysis bullosa
simplex, in spite of the unusual amount of hyperkeratoses. Light
and electron microscopy revealed a severely hyperkeratotic stratum
corneum and a collapsed keratin network in all suprabasal ker-
atinocytes, thus confirming the diagnosis of EHK. DNA sequencing
revealed a single nucleotide exchange in codon 160 of the K10
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Figure 4. Sequence analysis of exon 1 of the keratin 10 gene. The
sequence of one unaffected (I.1) family member and of the affected patient
II.1 are shown. The nucleotide transversion and the amino acid substitution
are marked by an arrow.
gene. This A to C transversion resulted in a substitution of a
hydrophobic (tyrosine) by an uncharged amino acid (serine) at
position 14 of the 1A region. The Y14S substitution is located
within the first 15 residues of the helix initiation motif that is
highly conserved among all intermediate filaments (Conway and
Parry, 1988). Cross-linking experiments predict important regions
of overlap between the helix initiation and termination motifs of
neighboring keratin molecules (Steinert et al, 1993); however,
position 14 does not appear to reside within the putative overlap
region. This tyrosine residue does occupy position d of the heptad
repeat, which is involved in hydrophobic interactions between
coiled-coil molecules, and is thought to stabilize the heterodimer.
Moreover, it is absolutely conserved among all type I keratins,
which implies that few, if any changes can be tolerated at this
position. This substitution would be expected to destroy hydro-
phobic interactions between residues of two adjacent keratins of
the two chain molecule, leading to a distortion of the alpha-helical
structure at the beginning of the 1A domain. Thus, the conformation
of the coiled-coil may be irregular over the first two heptads. This
could impede the next stage in assembly where the head-to-tail
overlap occurs (Steinert and Parry, 1993; Steinert et al, 1993).
Because a previous report correlating EHK phenotypes with
genotypes concluded that all cases with palmar/plantar hyperker-
atosis were associated with K1 mutations (DiGiovanna and Bale,
1994), we anticipated that, due to the severe palmoplantar involve-
ment, this patient would also harbor a K1 mutation. Clearly, the
Y14S substitution in K10 is an exception to the general conclusions
of this previous report. In fact, all mutations reported to date in
this residue of K10 have been associated with a severe phenotype.
The first mutation reported, a tyrosine to asparagine substitution
(Y14N), was discovered when we were providing prenatal diagnosis
for a family in which the father suffered from severe blistering as
a child and widespread hyperkeratosis as an adult (Rothnagel et al,
1994). The second report, a T to G transversion in codon 160 of
the keratin 10 gene, leading to a replacement of tyrosine by aspartic
acid (Y14D), was also associated with a severe phenotype (Chipev
et al, 1994).
These substitutions, Y14N and Y14D, combined with the Y14S
identified in this report, indicate that changes at this position of
the 1A region of K10 can be very deleterious and lead to severe
clinical disease. The small number of mutations reported in this
residue to date do not allow definitive conclusions correlating
phenotype with genotype; however, it is tempting to speculate that
certain mutations that lie just outside the overlap region between
the helix initiation and termination motifs, but cause a distortion
in the alpha-helical structure in this critical region of the heterod-
imer, may actually be more detrimental than mutations that affect
single residues within the overlap region. A severe alteration in the
conformation of the coiled-coil at the beginning of the rod domain
could affect multiple interactions between neighboring keratin
molecules in the overlap region. Further structure/function studies
will be required to confirm this prediction.
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